Wetherby Asset Management Inc Eli Lilly & CO Transaction History

Wetherby Asset Management Inc

$2.08 Billion
Q2 2024

A detailed history of Wetherby Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wetherby Asset Management Inc holds 26,315 shares of LLY stock, worth $23.1 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

26,315

Previous 26,302 0.05%

Holding current value

$23.1 Million

Previous $20.5 Million 16.44%

% of portfolio

1.15%

Previous 0.99%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $9,423 - $11,817	13 Added 0.05%	26,315 $23.8 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $118,440 - $158,456	-200 Reduced 0.75%	26,302 $20.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $122,369 - $144,257	233 Added 0.89%	26,502 $15.4 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $67,813 - $93,490	156 Added 0.6%	26,269 $14.1 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $145,206 - $194,157	414 Added 1.61%	26,113 $12.2 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $105,303 - $123,673	339 Added 1.34%	25,699 $8.83 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $34,405 - $40,089	107 Added 0.42%	25,360 $9.28 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $277,208 - $315,908	935 Added 3.84%	25,253 $8.17 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $413,635 - $485,668	1,484 Added 6.5%	24,318 $7.88 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $165,456 - $205,620	705 Added 3.19%	22,834 $6.54 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $65,881 - $81,758	293 Added 1.34%	22,129 $6.11 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $115,232 - $141,809	520 Added 2.44%	21,836 $5.05 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $122,774 - $158,807	680 Added 3.3%	21,316 $4.89 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $97,606 - $126,355	-594 Reduced 2.8%	20,636 $3.86 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $88,190 - $116,697	676 Added 3.29%	21,230 $3.59 Million
Q3 2020 Dec 16, 2020	SELL	$146.22 - $169.13 $152,068 - $175,895	-1,040 Reduced 4.82%	20,554 $3.04 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $80,567 - $93,190	551 Added 2.62%	21,594 $3.2 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $51,703 - $62,224	379 Added 1.83%	21,043 $3.46 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $169,170 - $209,384	1,421 Added 7.38%	20,664 $2.87 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $9,088 - $11,256	-85 Reduced 0.44%	19,243 $2.53 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $52,220 - $56,802	-489 Reduced 2.47%	19,328 $2.16 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $443 - $517	4 Added 0.02%	19,817 $2.2 Million
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $103,518 - $121,848	930 Added 4.93%	19,813 $2.57 Million
Q4 2018 Jan 30, 2019	BUY	$105.9 - $118.64 $43,419 - $48,642	410 Added 2.22%	18,883 $2.19 Million
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $38,207 - $47,752	445 Added 2.47%	18,473 $1.98 Million
Q2 2018 Jul 24, 2018	BUY	$75.7 - $86.88 $94,473 - $108,426	1,248 Added 7.44%	18,028 $1.54 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $163,781 - $193,333	-2,207 Reduced 11.62%	16,780 $1.3 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $152,326 - $163,387	1,859 Added 10.85%	18,987 $1.6 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1.32 Million - $1.47 Million	17,128	17,128 $1.47 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Eli Lilly & CO Transaction History